International Patent: SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST AIM2 AND THEIR USE

GENEVA, June 26 -- RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN filed a patent application (EP2025/085523) for “SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST AIM2 AND THEIR USE”. With publication no. WO/2026/120086, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....